Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease. [PDF]
Dartois V, Dick T.
europepmc +1 more source
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon. [PDF]
Kufa M +6 more
europepmc +1 more source
Linezolid pharmacokinetics in multidrug resistant tuberculosis (MDR TB): a systematic review, meta-analysis and Monte Carlo simulation [PDF]
Alffenaar, Jan-Willem C +11 more
core
The Structure, Properties, and Clinical Utility of Contezolid for Antituberculosis: A Narrative Review. [PDF]
Chen T, Li W, Shen F, Nie W, Wu F.
europepmc +1 more source
SuFEx-based antitubercular compound irreversibly inhibits Pks13. [PDF]
Krieger IV +44 more
europepmc +1 more source
Advances in Therapeutic Drug Monitoring and Pharmacokinetic Researches of Oxazolidinone Antibacterial Agents in the Elderly Patients. [PDF]
Liu T +10 more
europepmc +1 more source
Advancing Tuberculosis Treatment with Next-Generation Drugs and Smart Delivery Systems. [PDF]
Elbehiry A, Marzouk E, Abalkhail A.
europepmc +1 more source
Advancing the chemotherapy of tuberculous meningitis: a consensus view. [PDF]
Wasserman S +31 more
europepmc +1 more source
Facile Synthesis of Oxazolidinones as Potential Antibacterial Agents. [PDF]
Els SP +9 more
europepmc +1 more source

